Transgenomic, Inc. is a biotechnology company operates in two segments: Clinical Laboratories, Pharmacogenomics Services and Diagnostic Tools. The Company's clinical laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. In its Pharmacogenomics Services segment, its contract research organization provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by its pharmaceutical customers. It specializes in pharmacogenomic, biomarker and mutation discovery research serving pharmaceutical and biomedical industries worldwide for disease research, drug and diagnostic development and clinical trial support. In Its diagnostic tools segment, it offers WAVE System, which has applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. In September 2012, it acquired Axial Biotech�s ScoliScor Adolescent Idiopathic Scoliosis Prognostic Test.